Stocktoria
Syndax Pharmaceuticals Inc SNDX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-03-03
Syndax Pharmaceuticals Inc institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 7,906,765 | $162.3M |
| Point72 Asset Management, L.P. | 1,985,547 | $46.4M |
| D. E. Shaw & Co., Inc. | 1,601,896 | $37.4M |
| TWO SIGMA INVESTMENTS, LP | 1,579,596 | $36.9M |
| AQR CAPITAL MANAGEMENT LLC | 980,314 | $22.9M |
| CITADEL ADVISORS LLC | 767,542 | $17.9M |
| RENAISSANCE TECHNOLOGIES LLC | 498,200 | $11.6M |
| MILLENNIUM MANAGEMENT LLC | 199,524 | $4.7M |
Source: SEC EDGAR filings · CIK 0001395937 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.